Sabon Amfani da Allurar Hasken Sputnik azaman Mai haɓakawa na Duniya

A KYAUTA Kyauta 3 | eTurboNews | eTN
Avatar na Linda Hohnholz
Written by Linda Hohnholz

Akwai mutane biliyan 2 da suka karbi allurar rigakafin cutar ta China a cikin kasar da ma duniya baki daya. Kamar yadda kasar Sin ta ba da izinin yin cudanya da ashana tare da allurar cikin gida, allurar rigakafin Sputnik Light na Rasha na iya zama babban abin ƙarfafa ga waɗanda aka yi wa allurar rigakafin Sinawa a wasu ƙasashe na duniya don ƙarfafawa da tsawaita kariya daga COVID.

Hukumomin gudanarwa na kasar Sin sun amince da hada magungunan gida da ba a yi amfani da su ba kan COVID (musamman, Sinovac da Sinopharm) da yin amfani da wani alluran rigakafi daban-daban, gami da tushen adenoviral, a matsayin harbin mai kara kuzari wanda ke ba da wani tabbaci na ingancin hadawa da tsarin wasan da aka fara aiwatarwa. ta hanyar rigakafin Sputnik V na Rasha don ƙirƙirar rigakafi mai ƙarfi kuma mai dorewa, gami da bambance-bambancen Omicron.

Ana amfani da alluran rigakafin da kamfanonin kasar Sin (Sinovac da Sinopharm) suka samar tare da sama da allurai biliyan 4.7 da aka kawo a kasar Sin da ma duniya baki daya[1]. Yayin da majalisar gudanarwar kasar Sin ta ba da izinin haɓaka da haɓaka wasa kawai tare da allurar cikin gida[2], allurar rigakafin Sputnik Light na Rasha (bangaren farko na Sputnik V) na iya zama mafita don haɓaka waɗanda aka fara yi da allurar Sinawa a sauran ƙasashen da ke kewaye. duniya.

Hasken Sputnik ya riga ya nuna sakamako mai ƙarfi da aka yi amfani da shi azaman mai haɓakawa a cikin gwaji da gwaji, gami da na allurar da ba a kunna ba. Misali, binciken da aka gudanar a Argentina akan Sputnik Light hade tare da sauran alluran rigakafi ya nuna cewa maganin rigakafi da ƙwayoyin T-cell wanda Sputnik Light ya haifar a matsayin mai haɓaka maganin rigakafin Sinopharm wanda ba a kunna ba shine 10x mafi girma vs harbi biyu na Sinopharm. Har ila yau, binciken ya nuna cewa kowane "alurar rigakafi" hade tare da Sputnik Light tare da wasu alluran rigakafi kamar Moderna, AstraZeneca da Cansino sun samar da mafi girma antibody titer a ranar 14th bayan gudanar da kashi na biyu idan aka kwatanta da asali homologous (alalurar rigakafi guda ɗaya kamar na farko da na farko). kashi na biyu) tsarin kowane maganin rigakafi. Yin amfani da Hasken Sputnik a hade tare da duk sauran alluran rigakafin sun nuna ingantaccen bayanin martaba ba tare da wani mummunan mummunan al'amuran da suka biyo bayan allurar rigakafin a cikin kowane haɗuwa ba.      

Hanyar haɓakawa daban-daban ("alurar rigakafi" ta amfani da adenovirus serotype 26 a matsayin kashi na farko da kuma ɗan adam adenovirus serotype 5 a matsayin kashi na biyu) wanda Cibiyar Gamaleya ta Rasha ta fara aiki shine tushen Sputnik V, riga-kafi na farko da aka yiwa rajista a duniya game da coronavirus. Wannan hanyar ta tabbatar da samun nasara wajen ƙirƙirar rigakafi mai tsayi da ɗorewa daga coronavirus kamar yadda bayanai na ainihi suka nuna daga Hungary, San Marino, Argentina, Serbia, Bahrain, Mexico, UAE da sauran ƙasashe.

Ya zuwa yau an amince da Sputnik Light a cikin fiye da kasashe 30 masu yawan jama'a sama da biliyan 2.5 da Sputnik V - a cikin kasashe 71 da ke da yawan mutane fiye da biliyan 4.

Sputnik V yana haifar da mafi ƙarfi kuma mai dorewa amsawar rigakafi akan COVID (gami da bambance-bambancen Omicron) fiye da sauran alluran rigakafi, wanda Sputnik Light booster ya ƙara ƙarfafawa. Wani bincike na musamman na kwatance[3] da aka gudanar a Cibiyar Kula da Cututtuka ta Kasa ta Lazzaro Spallanzani a Italiya ta ƙungiyar 12 Italiyanci da masana kimiyya na Rasha 9 karkashin jagorancin Francesco Vaia, Daraktan Cibiyar Spallanzani da Alexander Gintsburg, Daraktan Cibiyar Gamaleya ya nuna cewa. Alurar rigakafin Sputnik V yana nuna fiye da sau 2 mafi girma titers na ƙwayoyin cuta neutralizing antibodies zuwa Omicron (B.1.1.529) bambance-bambancen fiye da 2 allurai na Pfizer allurai (sau 2.1 mafi girma a duka da 2.6 sau sama da watanni 3 bayan alurar riga kafi).

An gudanar da binciken a cikin daidaitattun yanayin dakin gwaje-gwaje akan kwatankwacin samfuran sera daga mutanen da aka yiwa alurar riga kafi da Sputnik V da Pfizer tare da irin wannan matakin na rigakafi na IgG da aikin kawar da kwayar cutar (VNA) akan bambance-bambancen Wuhan. Sputnik V ya nuna raguwa sosai (sau 2.6) na rage ayyukan kawar da kwayar cutar kan Omicron idan aka kwatanta da bambancin Wuhan fiye da allurar Pfizer (ragi sau 8.1 don Sputnik V sabanin raguwar ninki 21.4 don rigakafin Pfizer).

Game da marubucin

Avatar na Linda Hohnholz

Linda Hohnholz

Edita a shugaba don eTurboNews bisa ga eTN HQ.

Labarai
Sanarwa na
bako
0 comments
Bayanin Cikin Lissafi
Duba duk maganganu
0
Za a son tunanin ku, don Allah sharhi.x
()
x
Share zuwa...